MMP2 and central nervous system cancer: Based on the assumption that CHL is able to efficiently penetrate inside the cells [33], U-87 glioma cells were treated with different concentrations of CHL and the secretion of matrix metalloproteinase (MMP)-2 was monitored by zymography.